شماره ركورد كنفرانس :
3693
عنوان مقاله :
بررسي علل كم خوني)آنمي(دربيماران كليوي
پديدآورندگان :
مبين زهرا دانشكده پزشكي، گروه علوم آزمايشگاهي، دانشگاه آزاد اسلامي واحد زاهدان , افرازه دانيال دانشكده پزشكي، گروه علوم آزمايشگاهي، دانشگاه آزاد اسلامي واحد زاهدان
كليدواژه :
Anemia , Renal patients , Iron deficiency , erythropoietin
عنوان كنفرانس :
اولين كنگره بين المللي زيست پزشكي ICB2017
چكيده فارسي :
Introduction: Chronic renal failure stage of renal insufficiency it is said that all the no longer able to repel and not toxic waste and as a result, these materials will find accumulation in blood.Anemia is usually in the early stages of chronic kidney disease was created and can be used in all patients who are in the final stages it is seen.Insufficient Erythropoietin production is the main cause of anemia in patients with chronic kidney disease and iron deficiency is stored or available, the most common cause of decreased response to synthetic Erythropoietin in treatment of anemia of patients under dialysis, battered.
Methods: Collection of information from books, scientific articles and websites is an overview.
Results: The most common cause of the lack of response to treatment with erythropoietin being insufficient iron. Iron can be oral or intravenous administration of form but in the majority of patients treated with erythropoietin dialysis in our which are edible to maintain iron iron is not suitable and in most cases require intravenous iron, That is now the country s largest iron iron sucrose contained in venous or Venofer.
Conclusion: According to the studies, the most common cause of resistance to Erythropoietin is a deficiency of iron thus leading to the administration of erythropoietin First, the patient s iron reserves should be determined and the iron deficiency should be treated The amount of iron should be measured, as well as for the iron intake Injection is preferred to iron orally.